|

Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE

RECRUITINGN/ASponsored by China National Center for Cardiovascular Diseases
Actively Recruiting
PhaseN/A
SponsorChina National Center for Cardiovascular Diseases
Started2023-08-31
Est. completion2026-08-30
Eligibility
Age65 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06009588

Summary

This study aimed at comparing the performance of self-expandable valves versus balloon-expandable valves in patients with ascending aortic dilation undergoing transcatheter aortic valve replacement.

Eligibility

Age: 65 Years+Healthy volunteers accepted
Inclusion Criteria:

* Severe aortic stenosis;
* Transfemoral access;
* Preoperative aortic CT suggesting maximum ascending aortic diameter ≥45mm and \<55mm;
* Anticipated life expectancy \>1 year;
* Age ≥ 65 years.

Exclusion Criteria:

* Dominant aortic regurgitation,;
* A history of SAVR or TAVR;
* A history of aortic surgery;
* Emergent TAVR.

Conditions3

Aortic StenosisAscending Aortic DilatationHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.